Di'namik Therapies Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$20K
- Investors
-
3
Di'namik Therapies General Information
Description
Manufacturer of precision nanomedicines designed for oral cancer care. The company is currently operating in Stealth mode.
Contact Information
Corporate Office
- Toronto, Ontario
- Canada
Corporate Office
- Toronto, Ontario
- Canada
Di'namik Therapies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Accelerator/Incubator | 10-Mar-2025 | $20K | Completed | Stealth | ||
| 2. Accelerator/Incubator | Completed | Stealth | ||||
| 1. Accelerator/Incubator | Completed | Stealth |
Di'namik Therapies Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| University of Toronto Entrepreneurship | Accelerator/Incubator | |||
| PRiME Next-Generation Precision | Accelerator/Incubator | |||
| The UTEST Program | Accelerator/Incubator |
Di'namik Therapies FAQs
-
Where is Di'namik Therapies headquartered?
Di'namik Therapies is headquartered in Toronto, Canada.
-
What industry is Di'namik Therapies in?
Di'namik Therapies’s primary industry is Drug Discovery.
-
Is Di'namik Therapies a private or public company?
Di'namik Therapies is a Private company.
-
What is Di'namik Therapies’s current revenue?
The current revenue for Di'namik Therapies is .
-
How much funding has Di'namik Therapies raised over time?
Di'namik Therapies has raised $20K.
-
Who are Di'namik Therapies’s investors?
University of Toronto Entrepreneurship, PRiME Next-Generation Precision, and The UTEST Program have invested in Di'namik Therapies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process